nitrous oxide has been researched along with Glycogen Storage Disease Type II in 2 studies
Nitrous Oxide: Nitrogen oxide (N2O). A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream.
dinitrogen oxide : A nitrogen oxide consisting of linear unsymmetrical molecules with formula N2O. While it is the most used gaseous anaesthetic in the world, its major commercial use, due to its solubility under pressure in vegetable fats combined with its non-toxicity in low concentrations, is as an aerosol spray propellant and aerating agent for canisters of 'whipped' cream.
Glycogen Storage Disease Type II: An autosomal recessively inherited glycogen storage disease caused by GLUCAN 1,4-ALPHA-GLUCOSIDASE deficiency. Large amounts of GLYCOGEN accumulate in the LYSOSOMES of skeletal muscle (MUSCLE, SKELETAL); HEART; LIVER; SPINAL CORD; and BRAIN. Three forms have been described: infantile, childhood, and adult. The infantile form is fatal in infancy and presents with hypotonia and a hypertrophic cardiomyopathy (CARDIOMYOPATHY, HYPERTROPHIC). The childhood form usually presents in the second year of life with proximal weakness and respiratory symptoms. The adult form consists of a slowly progressive proximal myopathy. (From Muscle Nerve 1995;3:S61-9; Menkes, Textbook of Child Neurology, 5th ed, pp73-4)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pompe or glycogen storage disease type II is a genetic disorder affecting the cardiac and skeletal muscle." | 1.34 | [Anesthetic management for a child with pompe disease]. ( Hiroki, K; Miwa, T; Sato, Y; Yamaguchi, K, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, Y | 1 |
| Yamaguchi, K | 1 |
| Miwa, T | 1 |
| Hiroki, K | 1 |
| Kotani, N | 1 |
| Hashimoto, H | 1 |
| Hirota, K | 1 |
| Muraoka, M | 1 |
| Matsuki, A | 1 |
2 other studies available for nitrous oxide and Glycogen Storage Disease Type II
| Article | Year |
|---|---|
[Anesthetic management for a child with pompe disease].
Topics: Anesthesia, General; Child, Preschool; Clubfoot; Glycogen Storage Disease Type II; Humans; Intubatio | 2007 |
Prolonged respiratory depression after anesthesia for parathyroidectomy in a patient with juvenile type of acid maltase deficiency.
Topics: alpha-Glucosidases; Anesthetics, Inhalation; Child; Enflurane; Glucan 1,4-alpha-Glucosidase; Glycoge | 1996 |